References
- Aneja, B., Queen, A., Khan, P., Shamsi, F., Hussain, A., Hasan, P., Rizvi, M. M. A., Daniliuc, C. G., Alajmi, M. F., Mohsin, M., Hassan, M. I., & Abid, M. (2020). Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX. Bioorganic & Medicinal Chemistry, 28(9), 115424. https://doi.org/https://doi.org/10.1016/j.bmc.2020.115424
- Beloglazkina, A. A., Wobith, B., Barskaia, E. S., Zefirov, N. A., Majouga, A. G., Beloglazkina, E. K., Zyk, N. V., Kuznetsov, S. A., & Zefirova, O. N. (2016). Synthesis and biological testing of (5Z)-2-aryl-5-arylmethylidene-3,5-dihydro-4H-imidazol-4-ones as antimitotic agents. Medicinal Chemistry Research, 25(6), 1239–1249.
- Biovia, D. S. (2013). Discovery studio modeling environment. Dassault Systemes.
- Boaz, H., & Rollefson, G. (1950). The quenching of fluorescence. Deviations from the Stern-Volmer law. Journal of the American Chemical Society, 72(8), 3435–3443.
- Boriack-Sjodin, P. A., Heck, R. W., Laipis, P. J., Silverman, D. N., & Christianson, D. W. (1995). Structure determination of murine mitochondrial carbonic anhydrase V at 2.45-A resolution: Implications for catalytic proton transfer and inhibitor design. Proceedings of the National Academy of Sciences, 92(24), 10949–10953.
- Cannella, R., Clerici, F., Gelmi, M. L., Penso, M., & Pocar, D. (1996). A new synthesis of functionalized 2-alkylidenetetrahydro-5-furanones by tandem alkylation and translactonization reactions of 5(4H)-oxazolones. The Journal of Organic Chemistry, 61(5), 1854–1856. https://doi.org/https://doi.org/10.1021/jo951213n
- Capkauskaite, E., Zaksauskas, A., Ruibys, V., Linkuviene, V., Paketuryte, V., Gedgaudas, M., Kairys, V., & Matulis, D. (2018). Benzimidazole design, synthesis, and docking to build selective carbonic anhydrase VA inhibitors. Bioorganic and Medicinal Chemistry, 26, 675–687. https://doi.org/https://doi.org/10.1016/j.bmc.2017.12.035
- Carpene, C., Boulet, N., Chaplin, A., & Mercader, J. (2019). Past, present and future anti-obesity effects of flavin-containing and/or copper-containing amine oxidase inhibitors. Medicines (Basel), 6, E9. https://doi.org/https://doi.org/10.3390/medicines6010009.
- Chegwidden, W. R., & Spencer, I. M. (1996). Carbonic anhydrase provides bicarbonate for de novo lipogenesis in the locust. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology, 115(2), 247–254.
- Costa, G., Carta, F., Ambrosio, F. A., Artese, A., Ortuso, F., Moraca, F., Rocca, R., Romeo, I., Lupia, A., Maruca, A., Bagetta, D., Catalano, R., Vullo, D., Alcaro, S., & Supuran, C. T. (2019). A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors. European Journal of Medicinal Chemistry, 181, 111565. https://doi.org/https://doi.org/10.1016/j.ejmech.2019.111565
- de Castro, P. P., Carpanez, A. G., & Amarante, G. W. (2016). Azlactone reaction developments. Chemistry - A European Journal, 22(30), 10294–10318.
- Dissanayake, W. C., Sorrenson, B., Cognard, E., Hughes, W. E., & Shepherd, P. R. (2018). beta-catenin is important for the development of an insulin responsive pool of GLUT4 glucose transporters in 3T3-L1 adipocytes. Experimental Cell Research, 366(1), 49–54.
- Dodgson, S. J. (1987). Inhibition of mitochondrial carbonic anhydrase and ureagenesis: A discrepancy examined. Journal of Applied Physiology (1985), 63(5), 2134–2141. https://doi.org/https://doi.org/10.1152/jappl.1987.63.5.2134
- Dodgson, S. J., & Cherian, K. (1989). Mitochondrial carbonic anhydrase is involved in rat renal glucose synthesis. American Journal of Physiology-Endocrinology and Metabolism, 257(6), E791–E796.
- Dodgson, S. J., Shank, R. P., & Maryanoff, B. E. (2000). Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia, 41(s5), S35–S39.
- Fareed, G., Afza, N., Versiani, M. A., Fareed, N., Mughal, U. R., Kalhoro, M. A., Iqbal, L., & Lateef, M. (2013). Synthesis, spectroscopic characterization and pharmacological evaluation of oxazolone derivatives. Journal of the Serbian Chemical Society, 78(8), 1127–1134.
- Forster, R. E., & Dodgson, S. J. (2000). Membrane transport and provision of substrates for carbonic anhydrase in vertebrates. In W. R. Chegwidden, Y. Edwards & N. Carter (Eds.), The carbonic anhydrases - New horizons (pp. 263–280). Birkhauser Verlag.
- Fujikawa-Adachi, K., Nishimori, I., Taguchi, T., & Onishi, S. (1999). Human mitochondrial carbonic anhydrase VB. cDNA cloning, mRNA expression, subcellular localization, and mapping to chromosome x. The Journal of Biological Chemistry, 274(30), 21228–21233.
- Gilmour, K. M., & Perry, S. F. (2009). Carbonic anhydrase and acid-base regulation in fish. The Journal of Experimental Biology, 212(Pt 11), 1647–1661. https://doi.org/https://doi.org/10.1242/jeb.029181
- Gordon, A., & Price, L. H. (1999). Mood stabilization and weight loss with topiramate. The American Journal of Psychiatry, 156(6), 968–969. https://doi.org/https://doi.org/10.1176/ajp.156.6.968a
- Hazen, S. A., Waheed, A., Sly, W. S., LaNoue, K. F., & Lynch, C. J. (1996). Differentiation-dependent expression of CA V and the role of carbonic anhydrase isozymes in pyruvate carboxylation in adipocytes. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 10(4), 481–490. https://doi.org/https://doi.org/10.1096/fasebj.10.4.8647347
- Heck, R. W., Tanhauser, S. M., Manda, R., Tu, C., Laipis, P. J., & Silverman, D. N. (1994). Catalytic properties of mouse carbonic anhydrase V. The Journal of Biological Chemistry, 269(40), 24742–24746.
- Idrees, D., Kumar, S., Rehman, S. A. A., Gourinath, S., Islam, A., Ahmad, F., & Imtaiyaz Hassan, M. (2016). Cloning, expression, purification and characterization of human mitochondrial carbonic anhydrase VA. 3 Biotech, 6(1), 16. https://doi.org/https://doi.org/10.1007/s13205-015-0334-1
- Idrees, D., Prakash, A., Haque, M. A., Islam, A., Ahmad, F., & Hassan, M. I. (2016). Spectroscopic and MD simulation studies on unfolding processes of mitochondrial carbonic anhydrase VA induced by urea. Journal of Biomolecular Structure and Dynamics, 34(9), 1987–1997. https://doi.org/https://doi.org/10.1080/07391102.2015.1100552
- Idrees, D., Shahbaaz, M., Bisetty, K., Islam, A., Ahmad, F., & Hassan, M. I. (2017). Effect of pH on structure, function, and stability of mitochondrial carbonic anhydrase VA. Journal of Biomolecular Structure and Dynamics, 35(2), 449–461. https://doi.org/https://doi.org/10.1080/07391102.2016.1149097
- Imtaiyaz Hassan, M., Shajee, B., Waheed, A., Ahmad, F., & Sly, W. S. (2013). Structure, function and applications of carbonic anhydrase isozymes. Bioorganic & Medicinal Chemistry, 21(6), 1570–1582. https://doi.org/https://doi.org/10.1016/j.bmc.2012.04.044
- Joshi, H., Upadhyay, P., Karia, D., & Baxi, A. J. (2003). Synthesis of some novel imidazolinones as potent anticonvulsant agents. European Journal of Medicinal Chemistry, 38(9), 837–840.
- Kakkar, S., & Narasimhan, B. (2019). A comprehensive review on biological activities of oxazole derivatives. BMC Chemistry, 13(1), 16. https://doi.org/https://doi.org/10.1186/s13065-019-0531-9531.
- Keni, M., & Tepe, J. J. (2005). One-pot Friedel-Crafts/Robinson-Gabriel synthesis of oxazoles using oxazolone templates. The Journal of Organic Chemistry, 70(10), 4211–4213. https://doi.org/https://doi.org/10.1021/jo0501590
- Khan, K. M., Mughal, U. R., Khan, M. T. H., Perveen, S., & Choudhary, M. I. (2006). Oxazolones: New tyrosinase inhibitors; synthesis and their structure-activity relationships. Bioorganic & Medicinal Chemistry, 14, 6027–6033. https://doi.org/https://doi.org/10.1016/j.bmc.2006.05.014
- Khan, K. M., Mughal, U. R., Lodhi, M. A., & Choudhary, M. I. (2008). Synthesis and chymotrypsin inhibitory activity of substituted oxazolones. Letters in Drug Design & Discovery, 5(1), 52–56.
- Khan, N. S., Khan, P., Ansari, M. F., Srivastava, S., Hasan, G. M., Husain, M., & Hassan, M. I. (2018). Thienopyrimidine-chalcone hybrid molecules inhibit fas-activated serine/threonine kinase: An approach to ameliorate antiproliferation in human breast cancer cells. Molecular Pharmaceutics, 15(9), 4173–4189. https://doi.org/https://doi.org/10.1021/acs.molpharmaceut.8b00566
- Khan, P., Idrees, D., Moxley, M. A., Corbett, J. A., Ahmad, F., von Figura, G., Sly, W. S., Waheed, A., & Hassan, M. I. (2014). Luminol-based chemiluminescent signals: Clinical and non-clinical application and future uses. Applied Biochemistry and Biotechnology, 173(2), 333–355. https://doi.org/https://doi.org/10.1007/s12010-014-0850-1
- Khan, P., Queen, A., Mohammad, T., Smita Khan, N. S., Hafeez, Z. B., Hassan, M. I., & Ali, S. (2019). Identification of alpha-mangostin as a potential inhibitor of microtubule affinity regulating kinase 4. Journal of Natural Products, 82, 2252–2261. https://doi.org/https://doi.org/10.1021/acs.jnatprod.9b00372
- Khan, P., Rahman, S., Queen, A., Manzoor, S., Naz, F., Hasan, G. M., Luqman, S., Kim, J., Islam, A., Ahmad, F., & Hassan, M. I. (2017). Elucidation of dietary polyphenolics as potential inhibitor of microtubule affinity regulating kinase 4: In silico and and in vitro studies. Scientific Reports, 7(1), 1–15. https://doi.org/10.1038/s41598-017-09941-4.
- Lehtonen, J., Shen, B., Vihinen, M., Casini, A., Scozzafava, A., Supuran, C. T., Parkkila, A. K., Saarnio, J., Kivela, A. J., Waheed, A., Sly, W. S., & Parkkila, S. (2004). Characterization of CA XIII, a novel member of the carbonic anhydrase isozyme family. The Journal of Biological Chemistry, 279(4), 2719–2727. https://doi.org/https://doi.org/10.1074/jbc.M308984200
- McConnell, D., Frajola, W. J., & Deamer, D. W. (1961). Relation between the inorganic chemistry and biochemistry of bone mineralization. Science (New York, N.Y.), 133(3448), 281–282. https://doi.org/https://doi.org/10.1126/science.133.3448.281
- Mesaik, M. A., Rahat, S., Khan, K. M., Choudhary, M. I., Murad, S. Z. I., & Ahmad, A. (2004). Synthesis and immunomodulatory properties of selected oxazolone derivatives. Bioorganic & Medicinal Chemistry, 12, 2049–2057. https://doi.org/https://doi.org/10.1016/j.bmc.2004.02.034
- Minkin, C., & Jennings, J. M. (1972). Carbonic anhydrase and bone remodeling: sulfonamide inhibition of bone resorption in organ culture. Science (New York, N.Y.), 176(4038), 1031–1033. https://doi.org/https://doi.org/10.1126/science.176.4038.1031
- Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. Journal of Computational Chemistry, 30(16), 2785–2791.10.1002. https://doi.org/https://doi.org/10.1002/jcc.21256
- Mujumdar, P., Kopecka, J., Bua, S., Supuran, C. T., Riganti, C., & Poulsen, S. A. (2019). Carbonic anhydrase XII inhibitors overcome temozolomide resistance in glioblastoma. Journal of Medicinal Chemistry, 62(8), 4174–4192. https://doi.org/https://doi.org/10.1021/acs.jmedchem.9b00282
- Naqvi, A. A. T., Jairajpuri, D. S., Noman, O. M. A., Hussain, A., Islam, A., Ahmad, F., Alajmi, M. F., & Hassan, M. I. (2019). Evaluation of pyrazolopyrimidine derivatives as microtubule affinity regulating kinase 4 inhibitors: Towards therapeutic management of Alzheimer’s disease. Journal of Biomolecular Structure and Dynamics, 38(13), 3892–3907. https://doi.org/https://doi.org/10.1080/07391102.2019.1666745
- Naqvi, A. A. T., Mohammad, T., Hasan, G. M., & Hassan, M. I. (2018). Advancements in docking and molecular dynamics simulations towards ligand-receptor interactions and structure-function relationships. Current Topics in Medicinal Chemistry, 18(20), 1755–1768. https://doi.org/https://doi.org/10.2174/1568026618666181025114157.
- Naz, F., Khan, F. I., Mohammad, T., Khan, P., Manzoor, S., Hasan, G. M., Lobb, K. A., Luqman, S., Islam, A., Ahmad, F., & Hassan, M. I. (2018). Investigation of molecular mechanism of recognition between citral and MARK4: A newer therapeutic approach to attenuate cancer cell progression. International Journal of Biological Macromolecules, 107(Pt B), 2580–2589. https://doi.org/https://doi.org/10.1016/j.ijbiomac.2017.10.143
- Naz, F., Shahbaaz, M., Bisetty, K., Islam, A., Ahmad, F., & Hassan, M. I. (2015). Designing new kinase inhibitor derivatives as therapeutics against common complex diseases: Structural basis of microtubule affinity-regulating kinase 4 (MARK4) inhibition. Omics: A Journal of Integrative Biology, 19(11), 700–711. https://doi.org/https://doi.org/10.1089/omi.2015.0111
- Naz, H., Islam, A., Ahmad, F., & Hassan, M. I. (2016). Calcium/calmodulin-dependent protein kinase IV: A multifunctional enzyme and potential therapeutic target. Progress in Biophysics and Molecular Biology, 121(1), 54–65. https://doi.org/https://doi.org/10.1016/j.pbiomolbio.2015.12.016.
- Naz, H., Khan, P., Tarique, M., Rahman, S., Meena, A., Ahamad, S., Luqman, S., Islam, A., Ahmad, F., & Hassan, M. I. (2017). Binding studies and biological evaluation of β-carotene as a potential inhibitor of human calcium/calmodulin-dependent protein kinase IV. International Journal of Biological Macromolecules, 96, 161–170. https://doi.org/https://doi.org/10.1016/j.ijbiomac.2016.12.024
- Nishimori, I., Vullo, D., Innocenti, A., Scozzafava, A., Mastrolorenzo, A., & Supuran, C. T. (2005). Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. Journal of Medicinal Chemistry, 48(24), 7860–7866. https://doi.org/https://doi.org/10.1021/jm050483n
- Nocentini, A., & Supuran, C. T. (2018). Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: A patent review (2008–2018). Expert Opinion on Therapeutic Patents, 28(10), 729–740. https://doi.org/https://doi.org/10.1080/13543776.2018.1508453
- Okamoto, M., Takayama, K., Shimizu, T., Muroya, A., & Furuya, T. (2010). Structure-activity relationship of novel DAPK inhibitors identified by structure-based virtual screening. Bioorganic & Medicinal Chemistry, 18(7), 2728–2734. https://doi.org/https://doi.org/10.1016/j.bmc.2010.02.018
- Pasha, M. A., Jayashankara, V. P., Venugopala, K. N., & Rao, G. K. (2007). Zinc Oxide (ZnO): An efficient catalyst for the synthesis of 4-arylmethylidene-2-phenyl 5(4H)-oxazolones having antimicrobial activity. Journal of Pharmacology and Toxicology , 2(3), 264–270.
- Pastorekova, S., Parkkila, S., Pastorek, J., & Supuran, C. T. (2004). Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects. Journal of Enzyme Inhibition and Medicinal Chemistry, 19(3), 199–299.
- Pastorekova, S., Vullo, D., Casini, A., Scozzafava, A., Pastorek, J., Nishimori, I., & Supuran, C. T. (2005). Carbonic anhydrase inhibitors: Inhibition of the tumor-associated isozymes IX and XII with polyfluorinated aromatic/heterocyclic sulfonamides. Journal of Enzyme Inhibition and Medicinal Chemistry, 20(3), 211–217.
- Peerzada, M. N., Khan, P., Ahmad, K., Hassan, M. I., & Azam, A. (2018). Synthesis, characterization and biological evaluation of tertiary sulfonamide derivatives of pyridyl-indole based heteroaryl chalcone as potential carbonic anhydrase IX inhibitors and anticancer agents. European Journal of Medicinal Chemistry, 155, 13–23. https://doi.org/https://doi.org/10.1016/j.ejmech.2018.05.034
- Poli, G., Bozdag, M., Berrino, E., Angeli, A., Tuccinardi, T., Carta, F., & Supuran, C. T. (2020). N-aryl-N'-ureido-O-sulfamates as potent and selective inhibitors of hCA VB over hCA VA: Deciphering the binding mode of new potential agents in mitochondrial dysfunctions. Bioorganic Chemistry, 100, 103896. https://doi.org/https://doi.org/10.1016/j.bioorg.2020.103896
- Postel, R., & Sonnenberg, A. (2012). Carbonic anhydrase 5 regulates acid-base homeostasis in Zebrafish. PLoS ONE, 7(6), e39881.
- Price, T. O., Sheibani, N., & Shah, G. N. (2017). Regulation of high glucose-induced apoptosis of brain pericytes by mitochondrial CA VA: A specific target for prevention of diabetic cerebrovascular pathology. Biochimica et Biophysica Acta. Molecular Basis of Disease, 1863(4), 929–935.
- Queen, A., Khan, P., Idrees, D., Azam, A., & Hassan, M. I. (2018). Biological evaluation of p-toluene sulphonylhydrazone as carbonic anhydrase IX inhibitors: An approach to fight hypoxia-induced tumors. International Journal of Biological Macromolecules, 106, 840–850. https://doi.org/https://doi.org/10.1016/j.ijbiomac.2017.08.082
- Rao, Y. S. (1976). Reactions in polyphosphoric acid. I. New stereospecific synthesis of the E isomers of 2-phenyl-4-arylmethylene-2-oxazolin-5-ones. The Journal of Organic Chemistry, 41(4), 722–725.
- Rao, Y. S., & Filler, R. (1975). Geometric isomers of 2-aryl(aralkyl)-4-arylidene(alkylidene)-5-(4H)-oxazolones. Synthesis, 1975(12), 749–764.
- Salaroglio, I. C., Mujumdar, P., Annovazzi, L., Kopecka, J., Mellai, M., Schiffer, D., Poulsen, S.-A., & Riganti, C. (2018). Carbonic anhydrase XII inhibitors overcome P-glycoprotein-mediated resistance to temozolomide in glioblastoma. Molecular Cancer Therapeutics, 17(12), 2598–2609.
- Santos-Martins, D., Forli, S., Ramos, M. J., & Olson, A. J. (2014). AutoDock4(Zn): an improved AutoDock force field for small-molecule docking to zinc metalloproteins. Journal of Chemical Information and Modeling, 54(8), 2371–2379.10.1021. https://doi.org/https://doi.org/10.1021/ci500209e
- Shah, G. N., Hewett-Emmett, D., Grubb, J. H., Migas, M. C., Fleming, R. E., Waheed, A., & Sly, W. S. (2000). Mitochondrial carbonic anhydrase CA VB: Differences in tissue distribution and pattern of evolution from those of CA VA suggest distinct physiological roles. Proceedings of the National Academy of Sciences of the United States of America, 97(4), 1677–1682. https://doi.org/https://doi.org/10.1073/pnas.97.4.1677
- Shah, G. N., Rubbelke, T. S., Hendin, J., Nguyen, H., Waheed, A., Shoemaker, J. D., & Sly, W. S. (2013). Targeted mutagenesis of mitochondrial carbonic anhydrases VA and VB implicates both enzymes in ammonia detoxification and glucose metabolism. Proceedings of the National Academy of Sciences of the United States of America, 110(18), 7423–7428. https://doi.org/https://doi.org/10.1073/pnas.1305805110
- Shamsi, F., Hasan, P., Queen, A., Hussain, A., Khan, P., Zeya, B., King, H. M., Rana, S., Garrison, J., Alajmi, M. F., Rizvi, M. M. A., Zahid, M., Imtaiyaz Hassan, M., & Abid, M. (2020). Synthesis and SAR studies of novel 1,2,4-oxadiazole-sulfonamide based compounds as potential anticancer agents for colorectal cancer therapy. Bioorganic Chemistry, 98, 103754. https://doi.org/https://doi.org/10.1016/j.bioorg.2020.103754
- Sjoblom, B., Polentarutti, M., & Djinovic-Carugo, K. (2009). Structural study of X-ray induced activation of carbonic anhydrase. Proceedings of the National Academy of Sciences of the United States of America, 106(26), 10609–10613. https://doi.org/https://doi.org/10.1073/pnas.0904184106
- Sly, W. S., & Hu, P. Y. (1995). Human carbonic anhydrases and carbonic anhydrase deficiencies. Annual Review of Biochemistry, 64, 375–401. https://doi.org/https://doi.org/10.1146/annurev.bi.64.070195.002111
- Smaine, F.-Z., Pacchiano, F., Rami, M., Barragan-Montero, V., Vullo, D., Scozzafava, A., Winum, J.-Y., & Supuran, C. T. (2008). Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV. Bioorganic & Medicinal Chemistry Letters, 18(24), 6332–6335. https://doi.org/https://doi.org/10.1016/j.bmcl.2008.10.093
- Soldavini, J., & Kaunitz, J. D. (2013). Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity. Digestive Diseases and Sciences, 58(10), 2756–2766. https://doi.org/https://doi.org/10.1007/s10620-013-2744-4
- Supuran, C. T. (2003). Carbonic anhydrase inhibitors in the treatment and propylaxis of obesity. Expert Opinion on Therapeutic Patents, 13(10), 1545–1550.
- Supuran, C. T. (2004). Carbonic anhydrases: Catalytic and inhibition mechanisms, distribution and physiological roles. In C. T. Supuran, A. Scozzafava & J. Conway (Eds.), Carbonic anhydrase (pp. 1–23). CRC Press.
- Supuran, C. T. (2010). Carbonic anhydrase inhibitors. Bioorganic & Medicinal Chemistry Letters, 20(12), 3467–3474. https://doi.org/https://doi.org/10.1016/j.bmcl.2010.05.009
- Supuran, C. T. (2018). Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors. Expert Opinion on Investigational Drugs, 27(12), 963–970. https://doi.org/https://doi.org/10.1080/13543784.2018.1548608
- Supuran, C. T., & Scozzafava, A. (2002). Applications of carbonic anhydrase inhibitors and activators in therapy. Expert Opinion on Therapeutic Patents, 12(2), 217–242.
- Tandon, M., Coffen, D. L., Gallant, P., Keith, D., & Ashwell, M. A. (2004). Potent and selective inhibitors of bacterial methionyl tRNA synthetase derived from an oxazolone-dipeptide scaffold. Bioorganic & Medicinal Chemistry Letters, 14(8), 1909–1911. https://doi.org/https://doi.org/10.1016/j.bmcl.2004.01.094
- Tashian, R. E., Venta, P. J., Nicewander, P. H., & Hewett-Emmett, D. (1990). Evolution, structure and expression of the carbonic anhydrase multigene family. Progress in Clinical and Biological Research, 344, 159–175.
- Thakur, P. K., & Hassan, M. I. (2011). Discovering a potent small molecule inhibitor for gankyrin using de novo drug design approach. International Journal of Computational Biology and Drug Design, 4(4), 373–386. https://doi.org/https://doi.org/10.1504/IJCBDD.2011.044404
- Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461.10.1002. https://doi.org/https://doi.org/10.1002/jcc.21334
- Vullo, D., Franchi, M., Gallori, E., Antel, J., Scozzafava, A., & Supuran, C. T. (2004). Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides. Journal of Medicinal Chemistry, 47(5), 1272–1279. https://doi.org/https://doi.org/10.1021/jm031057+
- Wang, Z. (2010). Erlenmeyer-Plochl Azlactone Synthesis, Chapter 217. In Comprehensive Organic Name Reactions and Reagents (pp. 997–1000). John Wiley & Sons.
- Winum, J. Y., Scozzafava, A., Montero, J. L., & Supuran, C. T. (2005). Sulfamates and their therapeutic potential. Medicinal Research Reviews, 25(2), 186–228. https://doi.org/https://doi.org/10.1002/med.20021